Search Login Register

TNFR-Fc fusion protein (etanercept) Summary

Description: reduces tumor necrosis factor activity, as well as cytokine, chemokine, and stress hormone release; used to treat SPONDYLITIS, ANKYLOSING

Also Known As: etanercept; Enbrel; Immunex brand of etanercept; TNF receptor type II-IgG fusion protein; TNR 001 Show All >>

Networked: 3122 relevant articles (575 outcomes, 664 trials/studies) for this Drug

Key Diseases for which TNFR-Fc fusion protein is Relevant

  1. Psoriasis (Pustulosis Palmaris et Plantaris) : 156 outcomes 173 studies in 715 results
  2. Rheumatoid Arthritis : 126 outcomes 152 studies in 901 results
  3. Ankylosing Spondylitis : 51 outcomes 59 studies in 246 results
  4. Psoriatic Arthritis : 45 outcomes 57 studies in 297 results
  5. Juvenile Rheumatoid Arthritis (Juvenile Idiopathic Arthritis) : 43 outcomes 26 studies in 195 results
Show All >>

Drugs Related to TNFR-Fc fusion protein

  1. infliximab (Remicade)
  2. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  3. adalimumab (Humira)
  4. Methotrexate (Mexate)
  5. TNFR-Fc fusion protein (etanercept)
  6. Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
  7. monoclonal antibody CNTO 1275 (CNTO 1275)
  8. Antirheumatic Agents (DMARD)
  9. efalizumab
  10. golimumab
Show All >>

Therapies Related to TNFR-Fc fusion protein

  1. Phototherapy (Light Therapy)
  2. Aftercare (After-Treatment)
  3. Biological Therapy
  4. Remission Induction
  5. Laminectomy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.